Many alphaviruses are medically relevant; chikungunya virus, for example, is an emerging human pathogen responsible for major recent epidemics 3. There are currently no treatments for alphavirus ...

DURHAM, N.C. – An experimental vaccine based on a virus that causes encephalitis in the wild appears to block tumor growth in some cases of advanced cancer, according to researchers at Duke University ...

GAITHERSBURG, Md., Nov. 01, 2022 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) announced results from a Phase 2 study evaluating the safety and immunogenicity of the company’s adjuvanted ...

The chikungunya virus virus-like particle (CHIKV VLP) vaccine achieved 100% seroconversion in adults who had previously received alphavirus vaccines and alphavirus vaccine–naive control individuals, ...

Griffith University and an international team of researchers have moved a step closer to identifying a broad spectrum treatment for the dreaded arthritogenic alphavirus infections. The threat of a ...

Anti-tumor efficacy and PD-L1 expression in the tumor microenvironment after poxvirus-based active immunotherapy and PD-1 blockade. This is an ASCO Meeting Abstract from the 2015 ASCO Annual Meeting I ...

Do a person's antibodies work to block the COVID-19 virus from infecting one's system? Are these antibodies also capable of blocking emerging variants such as the omicrons? These are the questions ...

This report describes a transfection-independent system for packaging alphavirus replicon vectors using modified vaccinia virus Ankara (MVA) vectors to express all of the RNA components necessary for ...

WEST LAFAYETTE, Ind. – Two families of viruses, which were previously thought to be related and later were considered unrelated, are celebrating a scientific family reunion of sorts. In a study ...

An experimental vaccine based on a virus that causes encephalitis in the wild appears to block tumor growth in some cases of advanced cancer, according to new research. Scientists say the vaccine is ...